↓ Skip to main content
What is this page? Embed badge

Advances in multiple Sclerosis and Experimental Demyelinating Diseases

Overview of attention for book
Cover of 'Advances in multiple Sclerosis and Experimental Demyelinating Diseases'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.
  3. Altmetric Badge
    Chapter 2 Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.
  4. Altmetric Badge
    Chapter 3 Multiple sclerosis genetics.
  5. Altmetric Badge
    Chapter 4 Imaging of remyelination and neuronal health.
  6. Altmetric Badge
    Chapter 5 Immunological aspects of axon injury in multiple sclerosis.
  7. Altmetric Badge
    Chapter 6 The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.
  8. Altmetric Badge
    Chapter 7 Genetic Analysis of CNS Remyelination
  9. Altmetric Badge
    Chapter 8 Remyelination in Experimental Models of Toxin-Induced Demyelination
  10. Altmetric Badge
    Chapter 9 Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
  11. Altmetric Badge
    Chapter 10 Neuroimaging of demyelination and remyelination models.
  12. Altmetric Badge
    Chapter 11 Hormonal influences in multiple sclerosis.
  13. Altmetric Badge
    Chapter 12 Statins and demyelination.
  14. Altmetric Badge
    Chapter 13 Role of uric acid in multiple sclerosis.
  15. Altmetric Badge
    Chapter 14 Neuromyelitis Optica: Clinical Syndrome and the NMO-IgG Autoantibody Marker
Attention for Chapter 1: Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.
Altmetric Badge

Mentioned by

wikipedia
10 Wikipedia pages

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
40 Mendeley
Summary Wikipedia Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.
Chapter number 1
Book title
Advances in multiple Sclerosis and Experimental Demyelinating Diseases
Published in
Current topics in microbiology and immunology, January 2008
DOI 10.1007/978-3-540-73677-6_1
Pubmed ID
18219812
Book ISBNs
978-3-54-073676-9, 978-3-54-073677-6
Authors

Pittock SJ, Rodriguez M, Pittock, S. J., Rodriguez, M., S. J. Pittock, M. Rodriguez

Abstract

This chapter describes the natural history of multiple sclerosis and, in particular, reviews the controversy regarding the entity of benign multiple sclerosis. Based on the Olmsted County population prevalence cohort study performed at the Mayo Clinic, MS patients with EDSS scores of 2 or lower followed for a period of 5-10 years have a very small risk of developing disability over the next 10-20 years. Based on these findings, this chapter reviews the indications, efficacy, mode of action, and side effect profiles of the currently approved and available disease-modifying agents for the treatment of multiple sclerosis. The efficacy of these agents is discussed based on the concepts of evidence-based medicine and the natural history of the disease. We review the arguments for and against treating all patients with MS. The authors propose an individualized approach to the use of these agents in the MS population.

View on publisher site
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Brazil 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 20%
Student > Bachelor 8 20%
Student > Master 5 13%
Other 4 10%
Researcher 2 5%
Other 8 20%
Unknown 5 13%
Readers by discipline Count As %
Medicine and Dentistry 17 43%
Neuroscience 3 8%
Agricultural and Biological Sciences 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 6 15%
Unknown 7 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2020.
All research outputs
#7,451,584
of 22,780,967 outputs
Outputs from Current topics in microbiology and immunology
#200
of 672 outputs
Outputs of similar age
#42,841
of 156,493 outputs
Outputs of similar age from Current topics in microbiology and immunology
#8
of 17 outputs
Altmetric has tracked 22,780,967 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 672 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,493 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.

This page is provided by Altmetric.